AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $0.02 by 2600 percent. This is a 900 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $819.799 million which beat the analyst consensus estimate of $796.621 million by 2.91 percent. This is a 5.39 percent increase over sales of $777.882 million the same period last year.